Abstract
CutC is a novel copper homeostasis protein containing 248 amino acids. Here we report the cloning, expression, purification, crystallization and preliminary X-ray crystallographic studies of CutC from Shigella flexneri 2a. Purification of CutC and its selenomethionine (SeMet) derivate were done using immobilized metal ion affinity chromatography, size-exclusion and ion-exchange chromatography. The purified proteins were crystallized using the hanging drop vapor diffusion method. The diffraction data for the native and SeMet CutC, respectively, have been collected with resolution of 1.7 Å and 2.1 Å. They belong to the space group C2221 and similar cell dimension. The native protein crystals have cell parameters: a=75.3267, b=97.6718, c=132.6910.
Keywords: cutc, copper homeostasis protein, purification, crystallization, preliminary crystallographic studies, shigella flexneri
Protein & Peptide Letters
Title: Purification and Preliminary Crystallographic Studies of CutC, a Novel Copper Homeostasis Protein from Shigella flexneri
Volume: 12 Issue: 8
Author(s): Yong-Qun Zhu, De-Yu Zhu, Hong-Xia Lu, Na Yang, Gen-Pei Li and Da-Cheng Wang
Affiliation:
Keywords: cutc, copper homeostasis protein, purification, crystallization, preliminary crystallographic studies, shigella flexneri
Abstract: CutC is a novel copper homeostasis protein containing 248 amino acids. Here we report the cloning, expression, purification, crystallization and preliminary X-ray crystallographic studies of CutC from Shigella flexneri 2a. Purification of CutC and its selenomethionine (SeMet) derivate were done using immobilized metal ion affinity chromatography, size-exclusion and ion-exchange chromatography. The purified proteins were crystallized using the hanging drop vapor diffusion method. The diffraction data for the native and SeMet CutC, respectively, have been collected with resolution of 1.7 Å and 2.1 Å. They belong to the space group C2221 and similar cell dimension. The native protein crystals have cell parameters: a=75.3267, b=97.6718, c=132.6910.
Export Options
About this article
Cite this article as:
Zhu Yong-Qun, Zhu De-Yu, Lu Hong-Xia, Yang Na, Li Gen-Pei and Wang Da-Cheng, Purification and Preliminary Crystallographic Studies of CutC, a Novel Copper Homeostasis Protein from Shigella flexneri, Protein & Peptide Letters 2005; 12 (8) . https://dx.doi.org/10.2174/0929866054864184
DOI https://dx.doi.org/10.2174/0929866054864184 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Long-acting Injectable vs. Oral Antipsychotics: Adherence, Persistence and Switching over three Years of Real-life Analysis
Current Reviews in Clinical and Experimental Pharmacology Advances in Zebrafish High Content and High Throughput Technologies
Combinatorial Chemistry & High Throughput Screening Propofol: Therapeutic Indications and Side-Effects
Current Pharmaceutical Design Small Ruminant Lentiviruses and Human Immunodeficiency Virus: Cousins that Take a Long View
Current HIV Research Ontogeny of Human Conjugating Enzymes
Drug Metabolism Letters Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Current Neuropharmacology Microglial Activation in Alzheimers Disease
Current Alzheimer Research Glutamate and Psychosis Risk
Current Pharmaceutical Design Immunity to Tuberculosis and Novel Therapeutic Strategies
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Meet Our Editorial Board Member
Current Gene Therapy ATP Binding Cassette Transporter A1 (ABCA1) Associated Proteins:Potential Drug Targets in the Metabolic Syndrome and Atherosclerotic Disease?
Current Pharmaceutical Biotechnology The Search for α-Secretase and its Potential as a Therapeutic Approach to Alzheimers Disease
Current Medicinal Chemistry Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape
Current Neuropharmacology Comparison Among Aerobic Exercise and Other Types of Interventions to Treat Depression: A Systematic Review
CNS & Neurological Disorders - Drug Targets EDITORIAL [Hot Topic Recognition of Functional Roles of Free Radicals Guest Editor: István Bokkon]
Current Neuropharmacology Adverse Effects of Non-Stimulant ADHD Drugs: Atomoxetine, Alpha-Agonists
Current Psychopharmacology Practice of Psychotherapy by Biological Psychiatrists: An Achievable or Unachievable Expectation
Current Psychiatry Reviews A Critical Approach of the Current Treatment of Anxiety Disorders
Current Psychopharmacology New Analytical Tools for Studying Autoimmune Diseases
Current Pharmaceutical Design Recent Developments in the Discovery of Novel Antipsychotic Agents Modualating Dopamine and Serotonin Receptors
Current Drug Targets